Research Article
BibTex RIS Cite

Insan Lokosıt Antıjenlerı Ve Perıyodık Hastalık

Year 1988, Volume: 41 Issue: 2, 195 - 210, 30.06.1988
https://izlik.org/JA86FZ84JE

Abstract

One of the most remarkable discoveries in recent years is the involment of the major histocompatibility complex in immunologic reactions. set of The human leucocyte antigens (HLA) system represents a similar genes in man and comprises 5 closely linked genetic loci on chromosome 6. Transplantation antigens coded for the HLA-A, HLA-B, HLA-C, HLA-C and HLA-DR loci are readly idendified with the use of serologic technic. The connection with a particular HLA type may make it possible to In
distinguish different clinical forms of a disease. some disease the HLA region served as a genetic marker for recessive or dominantly inherid disease genes. Gen frequency and disease association differ in different geographic regions. In this investigation, we have come to conclusion that : Some of HLA antigens, A9, A10, Bis and B4o antigens showed a, relative risk, although it was at a lower rate, compared with the other types antigens. It will be possible to attain a more meaningful result as the number of cases increase.

Ethical Statement

-

Supporting Institution

-

Project Number

-

Thanks

-

References

  • 1. Albert ED, Mickey MR, Nicholas AC, Taresaki PF : Seven new HLA specificities and their distribition in three raels Teresaki PI - Histocompatibility testing 1070, Copenhageu-Munsgoard publishers, 221, 1970.
  • 2. Amiel FL, Study of the leucocyte phenotypes in Hodgkin’s disease in histocompatibity testing. Copenhageu, Munsgoard publishers, 79, 1967
  • 3. Chiristina MS, Hall PJ, Bedford PA, Booth CC. HLA antigens in coeliac disease associated with malignancy. Gut 24, 925. 1983.
  • 4. Crumpton MY. Scientific editor. HLA in medicine. 1987.
  • 5. Daussetf J. Nenna A. Presence d'une leuco-agglutinine dans le serum d'un cas d’agranulacytase chronigue. C R Soc Biol (Paris), 146 : 1539, 1952.
  • 6. Dausset J : Leucocytes and tissue groups. Vox Song 11 263, 1966.
  • 7. Dausset J: The HLA-A system, genetic and biological implication. Acta Pathol. Microbiol Scand LBJ 78, 529, 1970.
  • 8. Dausset J, Colombanif, Legronal L et al. Le deuxieme sub-locus du systeme HL-A. Nouv Rev Fr Hematol 8, 841, 1958.
  • 9. Dick HM, Patch BMRC : HLA and disease. Britsh Med Bull 34, 3, 271, 197s.
  • 10. Engelfriet CP, Heersche FN, Eijsvoogel VP : Demotration of leucocyte iso-antigens on skin fibroblasts by mean of the cytotoxic antibody test. Vox Song 11: 625, 1976.
  • 11. Fradkin A, Pras M, Zemer D. Gazit E. Famial mediterranean fever : No association of HLA with amyloidosis or colchicine treatment response Isr J Med Sci 21: 757-758, 1985.
  • 12. Forbes JF, Morris PJ : Leucocyte antigens in Hodgkin disease Lancet 2 : 849, 1970. 13. Hawkins BR, Hovliston JB, Dawkins RL . Distrubition of HLA-A, B and C antigens in an Australian population. Hum Genet 52, 193, 1979.
  • 14. HLA and disease. Editorials. Arch Intern Med 138, 527, 1978.
  • 15. Kissmeyer-nielson }', Thorsby E : Human transplantation antigens. Appendix, method in histocompatibility testing. Transplant T1p/cerrahi biilteni 7, 1, 83, 1974.
  • 16. Perkins AH. Human major histocompatibility complex. Basic Immunology 181, 1982.
  • 17. Roodff Von, Lecuwen A, Schippens AMJ. Leucocyte groups, the normal lymJC, phocyte transfer test and homograft sensivity in Balmer H, Eleton FJ, Eernise
  • 18. Histocompatibility testing Copenhagen, Munksgoard publishers 37, 1964,
  • 19. alford RL, Antibody diversity, histocompatibility system disease states and ageing. Lancet 2, 1226, 1970.
  • 20. William C, De Wolf MD, Bodupant MD, Edward J Yunis : HLA and disease Current concepts Human Path 11, 4, 332, 1980.
  • 21. Zervas JD, Delomore IW, Israels MC, Leucocyte phenotypes in Hodgkin disease. Lancet 2 : 634, 1970

Insan Lokosıt Antıjenlerı Ve Perıyodık Hastalık

Year 1988, Volume: 41 Issue: 2, 195 - 210, 30.06.1988
https://izlik.org/JA86FZ84JE

Abstract

Major histokompatibilite kompleksi ile ilgili olarak yapilan calismalar son yillarin en 6nemli arastirmalarindan biri olmustur. insan lékosit antijenleri 6. kromozom tzerinde 5 ayrl lokusta bulunurlar. insan lékosit antijenlerinin baz tipleri ile bazi hastaliklar arasinda 6nemli yaklasimlar bulundugu anlasilmistir. Bu antijenler hastaligin genetik markeri olarak resesif veya dominant 6zelligini verir. Periyodik hastalikta yapilan bu calismada AQ, A10, B18 ve B40 gibi baz antijen tiplerinde relatif risk orani cok yüksek olmamakla birlikte anlamlı bulunmustur.

Ethical Statement

-

Supporting Institution

-

Project Number

-

Thanks

-

References

  • 1. Albert ED, Mickey MR, Nicholas AC, Taresaki PF : Seven new HLA specificities and their distribition in three raels Teresaki PI - Histocompatibility testing 1070, Copenhageu-Munsgoard publishers, 221, 1970.
  • 2. Amiel FL, Study of the leucocyte phenotypes in Hodgkin’s disease in histocompatibity testing. Copenhageu, Munsgoard publishers, 79, 1967
  • 3. Chiristina MS, Hall PJ, Bedford PA, Booth CC. HLA antigens in coeliac disease associated with malignancy. Gut 24, 925. 1983.
  • 4. Crumpton MY. Scientific editor. HLA in medicine. 1987.
  • 5. Daussetf J. Nenna A. Presence d'une leuco-agglutinine dans le serum d'un cas d’agranulacytase chronigue. C R Soc Biol (Paris), 146 : 1539, 1952.
  • 6. Dausset J : Leucocytes and tissue groups. Vox Song 11 263, 1966.
  • 7. Dausset J: The HLA-A system, genetic and biological implication. Acta Pathol. Microbiol Scand LBJ 78, 529, 1970.
  • 8. Dausset J, Colombanif, Legronal L et al. Le deuxieme sub-locus du systeme HL-A. Nouv Rev Fr Hematol 8, 841, 1958.
  • 9. Dick HM, Patch BMRC : HLA and disease. Britsh Med Bull 34, 3, 271, 197s.
  • 10. Engelfriet CP, Heersche FN, Eijsvoogel VP : Demotration of leucocyte iso-antigens on skin fibroblasts by mean of the cytotoxic antibody test. Vox Song 11: 625, 1976.
  • 11. Fradkin A, Pras M, Zemer D. Gazit E. Famial mediterranean fever : No association of HLA with amyloidosis or colchicine treatment response Isr J Med Sci 21: 757-758, 1985.
  • 12. Forbes JF, Morris PJ : Leucocyte antigens in Hodgkin disease Lancet 2 : 849, 1970. 13. Hawkins BR, Hovliston JB, Dawkins RL . Distrubition of HLA-A, B and C antigens in an Australian population. Hum Genet 52, 193, 1979.
  • 14. HLA and disease. Editorials. Arch Intern Med 138, 527, 1978.
  • 15. Kissmeyer-nielson }', Thorsby E : Human transplantation antigens. Appendix, method in histocompatibility testing. Transplant T1p/cerrahi biilteni 7, 1, 83, 1974.
  • 16. Perkins AH. Human major histocompatibility complex. Basic Immunology 181, 1982.
  • 17. Roodff Von, Lecuwen A, Schippens AMJ. Leucocyte groups, the normal lymJC, phocyte transfer test and homograft sensivity in Balmer H, Eleton FJ, Eernise
  • 18. Histocompatibility testing Copenhagen, Munksgoard publishers 37, 1964,
  • 19. alford RL, Antibody diversity, histocompatibility system disease states and ageing. Lancet 2, 1226, 1970.
  • 20. William C, De Wolf MD, Bodupant MD, Edward J Yunis : HLA and disease Current concepts Human Path 11, 4, 332, 1980.
  • 21. Zervas JD, Delomore IW, Israels MC, Leucocyte phenotypes in Hodgkin disease. Lancet 2 : 634, 1970
There are 20 citations in total.

Details

Primary Language English
Subjects Gastroenterology Surgery
Journal Section Research Article
Authors

Negüz Sümer This is me

Project Number -
Publication Date June 30, 1988
IZ https://izlik.org/JA86FZ84JE
Published in Issue Year 1988 Volume: 41 Issue: 2

Cite

APA Sümer, N. (1988). Insan Lokosıt Antıjenlerı Ve Perıyodık Hastalık. Ankara Üniversitesi Tıp Fakültesi Mecmuası, 41(2), 195-210. https://izlik.org/JA86FZ84JE
AMA 1.Sümer N. Insan Lokosıt Antıjenlerı Ve Perıyodık Hastalık. Ankara Üniversitesi Tıp Fakültesi Mecmuası. 1988;41(2):195-210. https://izlik.org/JA86FZ84JE
Chicago Sümer, Negüz. 1988. “Insan Lokosıt Antıjenlerı Ve Perıyodık Hastalık”. Ankara Üniversitesi Tıp Fakültesi Mecmuası 41 (2): 195-210. https://izlik.org/JA86FZ84JE.
EndNote Sümer N (June 1, 1988) Insan Lokosıt Antıjenlerı Ve Perıyodık Hastalık. Ankara Üniversitesi Tıp Fakültesi Mecmuası 41 2 195–210.
IEEE [1]N. Sümer, “Insan Lokosıt Antıjenlerı Ve Perıyodık Hastalık”, Ankara Üniversitesi Tıp Fakültesi Mecmuası, vol. 41, no. 2, pp. 195–210, June 1988, [Online]. Available: https://izlik.org/JA86FZ84JE
ISNAD Sümer, Negüz. “Insan Lokosıt Antıjenlerı Ve Perıyodık Hastalık”. Ankara Üniversitesi Tıp Fakültesi Mecmuası 41/2 (June 1, 1988): 195-210. https://izlik.org/JA86FZ84JE.
JAMA 1.Sümer N. Insan Lokosıt Antıjenlerı Ve Perıyodık Hastalık. Ankara Üniversitesi Tıp Fakültesi Mecmuası. 1988;41:195–210.
MLA Sümer, Negüz. “Insan Lokosıt Antıjenlerı Ve Perıyodık Hastalık”. Ankara Üniversitesi Tıp Fakültesi Mecmuası, vol. 41, no. 2, June 1988, pp. 195-10, https://izlik.org/JA86FZ84JE.
Vancouver 1.Negüz Sümer. Insan Lokosıt Antıjenlerı Ve Perıyodık Hastalık. Ankara Üniversitesi Tıp Fakültesi Mecmuası [Internet]. 1988 Jun. 1;41(2):195-210. Available from: https://izlik.org/JA86FZ84JE